Onglyza Not Linked to Elevated Cancer Risk
Onglyza is not associated with an elevated cancer risk, according to the results of new analysis of data from the SAVOR-TIMI 53 clinical trial. Last year, findings from that same study prompted federal...
View ArticleOnglyza Heart Failure Cases Detailed in FDA Adverse Event Reports
Just months after the U.S. Food & Drug Administration (FDA) convened an advisory panel meeting to discuss a possible link between Onglyza (saxagliptin) and heart failure, a new analysis indicates...
View ArticleOnglyza Heart Failure Worries Could Raise Januvia Profile
Could recent concerns surrounding Onglyza and heart failure prove to be a positive for some other Type 2 diabetes drugs? That’s definitely a possibility in the case of Januvia, which recently passed...
View ArticleOnglyza Dropped From Formulary Amid Heart Failure Concerns
A potential link between Onglyza and heart failure has prompted a major pharmacy benefits manager to remove the Type 2 diabetes drug from its 2016 formulary. The exclusion by Express Scripts will also...
View ArticleManufacturer Funded Study Disputes Onglyza Heart Failure Risk
Mere months after a panel of health experts called for new label warnings regarding a possible link between Onglyza and heart failure, the manufacturer of the Type 2 diabetes drug released new research...
View ArticleNew Onglyza Safety Concern: Severe Joint Pain
Just months after its a group of medical advisers recommended that an Onglyza heart failure warning be added to its label, the U.S. Food & Drug Administration (FDA) is warning about another...
View ArticleOnglyza Side Effects: Bone Fracture Risk Dubbed “Neutral”
Patients who rely on Onglyza to control Type 2 diabetes have one less safety issue to worry about. According to a newly-released study, Onglyza neither increases nor decreases the risk for bone...
View ArticleOnglyza and Heart Failure: Still No Word from the FDA
U.S. health regulators have yet to announce any label changes for Onglyza, a Type 2 diabetes medication that may be associated with an increased risk of heart failure. The U.S. Food & Drug...
View ArticleOnglyza Combo Treatment Rejected by FDA
The U.S. Food & Drug Administration (FDA) has given the thumbs down to a combination Type 2 diabetes medication being developed by AstraZeneca that would combine the active ingredients found in...
View ArticleOnglyza Lawsuit Alleges Wrongful Death From Heart Failure
A new Onglyza lawsuit claims that the Type 2 diabetes medication caused a Chicago woman’s wrongful death from heart failure. The complaint, which is currently pending in Cook County Circuit Court in...
View Article
More Pages to Explore .....